<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> is associated with an increased risk of the development of oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Endoscopic surveillance every 2-5 years has been recommended to prevent <z:hpo ids='HP_0011420'>death</z:hpo> from <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>AIM: To assess the cost-effectiveness of this strategy </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: The incremental cost-effectiveness of surveillance (as compared to no surveillance) was analysed with a computer model of a Markov process </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Compared to no surveillance, the incremental cost-effectiveness of bi-annual endoscopy is 16,695 dollars per life-year saved </plain></SENT>
<SENT sid="5" pm="."><plain>Surveillance is less cost-effective if the incidence rate of oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> is low and the 5-year survival rate is high </plain></SENT>
<SENT sid="6" pm="."><plain>For surveillance to be cost-effective, there should be little reduction in health-related quality of life following surgical oesophagectomy to prevent <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Moreover, endoscopic surveillance and oesophagectomy need to be efficacious in reliably diagnosing high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and preventing <z:hpo ids='HP_0011420'>deaths</z:hpo> from <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>If such ideal conditions of surveillance are not met, the cost per life-year saved could rise five-fold </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Endoscopic surveillance of patients with <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> may be a cost-effective means to prevent <z:hpo ids='HP_0011420'>death</z:hpo> from oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
</text></document>